Globus Medical EBITDA Margin 2010-2025 | GMED
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Globus Medical (GMED) over the last 10 years. The current EBITDA margin for Globus Medical as of March 31, 2025 is .
| Globus Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.51B | $0.71B | 28.12% |
| 2024-12-31 | $2.52B | $0.66B | 26.23% |
| 2024-09-30 | $2.48B | $0.62B | 25.04% |
| 2024-06-30 | $2.24B | $0.50B | 22.16% |
| 2024-03-31 | $1.90B | $0.41B | 21.47% |
| 2023-12-31 | $1.57B | $0.36B | 22.87% |
| 2023-09-30 | $1.23B | $0.29B | 23.55% |
| 2023-06-30 | $1.10B | $0.31B | 28.35% |
| 2023-03-31 | $1.07B | $0.31B | 29.19% |
| 2022-12-31 | $1.02B | $0.30B | 29.52% |
| 2022-09-30 | $1.00B | $0.27B | 26.63% |
| 2022-06-30 | $0.98B | $0.26B | 26.46% |
| 2022-03-31 | $0.96B | $0.24B | 24.74% |
| 2021-12-31 | $0.96B | $0.25B | 25.57% |
| 2021-09-30 | $0.94B | $0.29B | 30.29% |
| 2021-06-30 | $0.93B | $0.28B | 30.20% |
| 2021-03-31 | $0.83B | $0.20B | 24.73% |
| 2020-12-31 | $0.79B | $0.18B | 22.18% |
| 2020-09-30 | $0.77B | $0.16B | 21.22% |
| 2020-06-30 | $0.75B | $0.15B | 20.32% |
| 2020-03-31 | $0.79B | $0.22B | 27.33% |
| 2019-12-31 | $0.79B | $0.22B | 28.37% |
| 2019-09-30 | $0.77B | $0.21B | 27.79% |
| 2019-06-30 | $0.74B | $0.21B | 27.99% |
| 2019-03-31 | $0.72B | $0.21B | 28.57% |
| 2018-12-31 | $0.71B | $0.21B | 29.92% |
| 2018-09-30 | $0.69B | $0.22B | 31.21% |
| 2018-06-30 | $0.68B | $0.21B | 31.70% |
| 2018-03-31 | $0.65B | $0.21B | 32.11% |
| 2017-12-31 | $0.64B | $0.21B | 32.70% |
| 2017-09-30 | $0.61B | $0.21B | 33.82% |
| 2017-06-30 | $0.60B | $0.21B | 34.56% |
| 2017-03-31 | $0.58B | $0.20B | 34.94% |
| 2016-12-31 | $0.56B | $0.20B | 35.28% |
| 2016-09-30 | $0.56B | $0.21B | 36.94% |
| 2016-06-30 | $0.56B | $0.21B | 37.23% |
| 2016-03-31 | $0.55B | $0.21B | 37.07% |
| 2015-12-31 | $0.55B | $0.20B | 36.63% |
| 2015-09-30 | $0.53B | $0.18B | 34.40% |
| 2015-06-30 | $0.51B | $0.18B | 34.31% |
| 2015-03-31 | $0.49B | $0.17B | 34.48% |
| 2014-12-31 | $0.48B | $0.16B | 34.32% |
| 2014-09-30 | $0.46B | $0.16B | 33.62% |
| 2014-06-30 | $0.45B | $0.15B | 33.11% |
| 2014-03-31 | $0.44B | $0.13B | 28.89% |
| 2013-12-31 | $0.43B | $0.12B | 28.57% |
| 2013-09-30 | $0.42B | $0.12B | 28.57% |
| 2013-06-30 | $0.41B | $0.12B | 28.68% |
| 2013-03-31 | $0.40B | $0.14B | 34.01% |
| 2012-12-31 | $0.39B | $0.13B | 34.37% |
| 2012-09-30 | $0.37B | $0.13B | 33.96% |
| 2012-06-30 | $0.36B | $0.13B | 34.71% |
| 2012-03-31 | $0.35B | $0.12B | 34.20% |
| 2011-12-31 | $0.33B | $0.11B | 34.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.982B | $2.519B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $198.309B | 86.86 |
| Thermo Fisher Scientific (TMO) | United States | $149.665B | 18.10 |
| Edwards Lifesciences (EW) | United States | $45.813B | 30.04 |
| Alcon (ALC) | Switzerland | $42.010B | 28.39 |
| IDEXX Laboratories (IDXX) | United States | $41.401B | 47.58 |
| DexCom (DXCM) | United States | $33.529B | 51.82 |
| IQVIA Holdings (IQV) | United States | $24.064B | 13.48 |
| STERIS (STE) | Ireland | $23.814B | 26.23 |
| Mettler-Toledo (MTD) | United States | $23.716B | 28.20 |
| Waters (WAT) | United States | $20.452B | 28.86 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.615B | 0.00 |
| Hologic (HOLX) | United States | $13.819B | 15.02 |
| Sysmex ADR (SSMXY) | Japan | $10.581B | 30.02 |
| Penumbra (PEN) | United States | $9.920B | 77.86 |
| Masimo (MASI) | United States | $8.948B | 33.01 |
| Glaukos (GKOS) | United States | $5.416B | 0.00 |
| Teleflex (TFX) | United States | $5.288B | 8.73 |
| TransMedics (TMDX) | United States | $4.192B | 91.13 |
| Integer Holdings (ITGR) | United States | $4.106B | 21.52 |
| PROCEPT BioRobotics (PRCT) | United States | $3.206B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.367B | 14.09 |
| Veracyte (VCYT) | United States | $2.094B | 29.39 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.19 |
| Elekta AB (EKTAY) | Sweden | $1.985B | 17.84 |
| Alphatec Holdings (ATEC) | United States | $1.798B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.226B | 114.84 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.957B | 5.09 |
| Beta Bionics (BBNX) | United States | $0.810B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.28 |
| RxSight (RXST) | United States | $0.631B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.568B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.534B | 12.53 |
| AxoGen (AXGN) | United States | $0.500B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| NeuroPace (NPCE) | United States | $0.428B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| AngioDynamics (ANGO) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.296B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.93 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.201B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.169B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.46 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |